SAN FRANCISCO and SUZHOU, China, Jan. 15, 2025 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of oncology, cardiovascular and metabolic,...
Read More Details
Finally We wish PressBee provided you with enough information of ( Innovent Receives NMPA Breakthrough Therapy Designation for IBI343 (Anti-CLDN18.2 ADC) as Monotherapy for Advanced Pancreatic Cancer )
Also on site :
- Robert De Niro, 81, Makes Rare Public Appearance With Daughter Helen, 13
- Callum Turner’s Net Worth at the Time of His Engagement to Dua Lipa
- '80s Metal Legend Celebrates the Legacy of Brian Wilson: 'A Huge Inspiration'